519 672 2121
Close mobile menu
Showing 241 - 250 of 776

Zantac (ranitidine)

Siskinds are class counsel in proposed class proceedings against manufacturers and distributors of Zantac-brand drugs and other pharmaceuticals containing the active ingredient Ranitidine. Zantac/Ranitidine is used to treat gastrointestinal conditions such as acid indigestion, heartburn, sour stomach, and gastroesophageal reflux disease. The ingestion of Zantac/Ranitidine has been linked to exposure to high levels of NDMA,...

Continue reading the post titled Zantac (ranitidine)

JUUL e-cigarettes

Siskinds LLP has filed a proposed class action alleging that JUUL Labs, Inc., JUUL Labs Canada Ltd. and Altria Group, Inc. deceptively marketed its e cigarette products to Canadians. This action is about the deceptive marketing of JUUL’s e-cigarette products. The Plaintiff alleges that JUUL failed to properly inform Canadians, especially young adolescents and adults, of...

Continue reading the post titled JUUL e-cigarettes

Pharmacists

As busy professionals, pharmacists may experience rapid change as their careers and personal circumstances advance. Our experience in advising pharmacists on a variety of legal issues allows us to offer a comprehensive, multi-disciplinary suite of services tailored to assist pharmacists throughout their personal lives, their career, and into retirement.

Continue reading the post titled Pharmacists

SSA Bonds

The law firms of Siskinds LLP, Sotos LLP, Koskie Minsky LLP, and Camp Fiorante Matthews Mogerman LLP are counsel in a class action against financial institutions (the “Defendants”) who conspired to fix, raise, decrease, maintain, stabilize, control or enhance unreasonably the price of supranational, sub-sovereign and agency bonds (“SSA bonds”) Beginning at least as early...

Continue reading the post titled SSA Bonds

Valeant Pharmaceuticals

Siskinds LLP (“Siskinds”) is co-counsel in proposed securities class actions against Valeant Pharmaceuticals International, Inc. (“Valeant”), certain of its directors and officers, and its auditor PricewaterhouseCoopers LLP (“PwC”). These class actions arise from the circumstances surrounding Valeant’s previously undisclosed relationships with Philidor Rx Services, LLC and other specialty pharmacies in the conduct of its business...

Continue reading the post titled Valeant Pharmaceuticals

Manulife Financial Corporation

Please be advised that the claims process is now complete and all payments have been distributed. This action, which was commenced in July 2009, alleges that Manulife Financial Corporation (“Manulife”) and certain of its current and former officers and directors negligently made misrepresentations relating to Manulife’s risk management practices and policies during the period between...

Continue reading the post titled Manulife Financial Corporation

Diet Drugs

Settlement Notice: The deadline for applying to receive settlement benefits has passed and all settlement funds have been distributed. There are 2 separate Class Actions underway involving the diet drugs Fenfluramine Dexfenfluramine. Fenfluramine was sold under the trade names of Ponderal and Pondimin. Dexfenfluramine was sold under the trade name of Redux. We are class...

Continue reading the post titled Diet Drugs